Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2025-12-24 @ 11:04 PM
NCT ID:
NCT00202969
Eligibility Criteria:
Inclusion Criteria:
* Non-prior chemotherapy treated advanced gastric adenocarcinoma
* Age 18 and over
* Performance status 0, 1, or 2 (ECOG)
* Life expectancy 3 months
* Hematopoietic WBC lower limit of normal-12,000/mm\^3 Absolute granulocyte count ≥ 2,000/mm\^3 Platelet count ≥ 100,000/mm\^3 Hemoglobin ≥ 8.0 g/dL
* Hepatic AST and ALT ≤ 100 U/L ALP ≤ 2 times upper limit of normal (ULN) Bilirubin ≤ 1.5 mg/dL
* Renal Plasma creatinine ≤ ULN Creatinine clearance ≥ 60 mL/min
Exclusion Criteria:
* Interstitial pneumonia, pulmonary fibrosis
* Myocardial infarction within the last 6 months, severe/unstable angina, congestive heart failure
* Intestinal paralysis, intestinal obstruction, uncontrollable diabetes
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00202969
Study Brief:
Protocol Section:
NCT00202969